Profile picture

Doctor Katarzyna Byczkowska

National Institute of Cardiology, Warsaw (Poland)
Membership: ESC Professional Member EACVI Member
Follow
Biography
Katarzyna Byczkowska, MD&PhD, Graduate of Postgraduate Studies of Heart Failure in University of Zurich, a certified cardiologist, heart failure and transplant specialist in training, certified echocardiographer and currently serving in Heart Failure and Heart Transplantation Department and Mechanical Circulatory Support Department in National Institute of Cardiology in Warsaw. She has completed Advanced Heart Failure Course of ESC, Hypertrophic Cardiomyopathy Imaging Course of EACVI and The EACVI Teaching Course on Thoracic Echocardiography. Her main clinical interests and research focus on cardiac imaging, heart failure and cardiomyopathies.
Logo ESC

Contributor content

Efficacy of sodium-glucose cotransporter - 2 inhibitors in patients after implantation of the left ventricular assist device
Presentation
Efficacy of sodium-glucose cotransporter - 2 inhibitors in patients after implantation of the left ventricular assist device
Left ventricular filling pressure as a determinant of risk stratification in patients undergoing transcatheter aortic valve implantation
Presentation
Left ventricular filling pressure as a determinant of risk stratification in patients undergoing transcatheter aortic valve implantation
Left ventricular lobal longitudinal strain as a prognostic marker in low-risk patients undergoing TAVI.
Presentation
Left ventricular lobal longitudinal strain as a prognostic marker in low-risk patients undergoing TAVI.
Katz frailty syndrom has no predictive value in low-risk patients undergoing transcatheter aortic valve implantation
Presentation
Katz frailty syndrom has no predictive value in low-risk patients undergoing transcatheter aortic valve implantation
Left ventricular deformation in patients undergoing TAVI
Presentation
Left ventricular deformation in patients undergoing TAVI
Frailty syndrom as a predictive factor in patients undergoing TAVI
Presentation
Frailty syndrom as a predictive factor in patients undergoing TAVI

ESC 365 is supported by